Conjugates for treating diseases caused by PSMA expressing cells

摘要

#$%^&*AU2020202904A120200521.pdf#####Abstract The invention described herein pertains to the diagnosis, imaging, and/or treatment of pathogenic cell populations. In particular, the invention described herein pertains to the diagnosis, imaging, and/or treatment of diseases caused by PSMA expressing 5 cells, such as prostate cancer cells, using compounds capable of targeting PSMA expressing cells.